TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Kidney fibrosis is a common pathophysiological mechanism of chronic kidney disease (CKD) progression caused by several underlying kidney diseases. Among various contributors to kidney fibrosis, transforming growth factor-β1 (TGF-β1) is the major factor driving fibrosis. TGF-β1 exerts its profibrotic...
Saved in:
Main Authors: | Cheol Ho Park (Author), Tae-Hyun Yoo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease
by: Jinxiang Li, et al.
Published: (2022) -
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
by: Xiao-Yong Yu, et al.
Published: (2022) -
TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease
by: Sung Il Kim, et al.
Published: (2012) -
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
by: Kelly L. Walton, et al.
Published: (2017) -
Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1
by: Xuan Li, et al.
Published: (2019)